DSM Will Divest Side-Chain Business | November 24, 2008 Issue - Vol. 86 Issue 47 | Chemical & Engineering News
Volume 86 Issue 47 | p. 19 | Concentrates
Issue Date: November 24, 2008

DSM Will Divest Side-Chain Business

Department: Business

DSM has agreed to sell DSM Deretil, a maker of antibiotic side chains, to a management group. DSM says the transaction will allow its anti-infectives unit "to fully focus on its core future activity" in generic antibiotics. Deretil President Lluis Franquesa says his company will proceed with a previously announced plan to close part of its main plant in Villaricos, Spain, and move production to China. Deretil's sales are about $44 million per year.

 
Chemical & Engineering News
ISSN 0009-2347
Copyright © American Chemical Society

Leave A Comment

*Required to comment